FXR agonists with sustained systemic rather than transient intestinal exposure are more efficacious in a diet-induced obese non-alcoholic steatohepatitis mouse modelB. Wagner, D. Brigham,K.-J. Lee,A. Ortiz,N. Lu,J. Qian,K. Douglas,J. Nagasawa, S. Govek,M. Feigh, S. Veidal,N. Vrang, K. Song,N. SmithJournal of Hepatology（2017）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
